[Allergy and intolerance to nonsteroidal anti-inflammatory drugs in children].
Alergia e intolerancia a antiinflamatorios no esteroideos en pediatría.
allergy
hypersensitivity
non-steroidal antiinflammatory agents
pediatrics
Journal
Archivos argentinos de pediatria
ISSN: 1668-3501
Titre abrégé: Arch Argent Pediatr
Pays: Argentina
ID NLM: 0372460
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
11
07
2019
accepted:
29
07
2019
entrez:
28
1
2020
pubmed:
28
1
2020
medline:
14
1
2021
Statut:
ppublish
Résumé
Nonsteroidal anti-inflammatory drugs are widely prescribed in children. They are the second cause of drug's reactions in pediatrics after beta-lactam antibiotics, however only a part of them are hypersensitivity reactions. The prevalence of these reactions to nonsteroidal anti-inflammatory drugs in children is 0.3 %, increasing to 5 % in asthmatics. The different physiopathological mechanisms involved (inhibition of cyclooxygenase, immunoglobulin E-mediated hypersensitivity, reactive T lymphocytes and/or disturbance of innate immunity) will cause different clinical entities with diverse symptoms. The confusion between the common symptoms of a viral infection and a hypersensitivity reaction, and the variability of the clinical presentations make diagnosis a real challenge. A detailed clinical history, laboratory, skin and controlled provocation tests will provide strategies for each patient, without labeling a child who is not an allergic one, or taking unnecessary risks with those who are sensitized. Los antiinflamatorios no esteroideos son ampliamente recetados en niños. Constituyen la segunda causa de reacciones a medicamentos en pediatría después de los antibióticos betalactámicos; sin embargo, solo una parte de estas son reacciones de hipersensibilidad. La prevalencia de dichas reacciones a antiinflamatorios no esteroideos en niños es del 0,3 % y aumenta al 5 % en asmáticos. Los mecanismos fisiopatológicos involucrados (inhibición de la ciclooxigenasa, hipersensibilidad mediada por inmunoglobulina E, linfocitos T reactivos y/o afectación de la inmunidad innata) darán lugar a diferentes entidades clínicas con sintomatología dispar. La confusión con síntomas propios de procesos virales y la variabilidad clínica hacen del diagnóstico de certeza un verdadero desafío. Una historia clínica detallada, análisis de laboratorio, pruebas cutáneas y de provocación controlada permitirán definir estrategias para cada paciente en particular sin etiquetar como alérgico a un niño que no lo es ni exponer a riesgos innecesarios a quien está sensibilizado.
Autres résumés
Type: Publisher
(spa)
Los antiinflamatorios no esteroideos son ampliamente recetados en niños. Constituyen la segunda causa de reacciones a medicamentos en pediatría después de los antibióticos betalactámicos; sin embargo, solo una parte de estas son reacciones de hipersensibilidad. La prevalencia de dichas reacciones a antiinflamatorios no esteroideos en niños es del 0,3 % y aumenta al 5 % en asmáticos. Los mecanismos fisiopatológicos involucrados (inhibición de la ciclooxigenasa, hipersensibilidad mediada por inmunoglobulina E, linfocitos T reactivos y/o afectación de la inmunidad innata) darán lugar a diferentes entidades clínicas con sintomatología dispar. La confusión con síntomas propios de procesos virales y la variabilidad clínica hacen del diagnóstico de certeza un verdadero desafío. Una historia clínica detallada, análisis de laboratorio, pruebas cutáneas y de provocación controlada permitirán definir estrategias para cada paciente en particular sin etiquetar como alérgico a un niño que no lo es ni exponer a riesgos innecesarios a quien está sensibilizado.
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Types de publication
Journal Article
Langues
spa
Sous-ensembles de citation
IM
Pagination
S1-S11Investigateurs
María P Sarraquigne
(MP)
Andrea I Mariño
(AI)
Ricardo Saranz
(R)
Mauricio Coletta
(M)
Karina López
(K)
María Del P Bovina Martijena
(MDP)
Claudio Parisi
(C)
Julio Orellana
(J)
Claudio Agüero
(C)
Viviana Seisdedos
(V)
Alejandro Lozano
(A)
Jorge F Máspero
(JF)
Raúl V Boudet
(RV)
Juan M Suárez García
(JM)
Gloria Bandín
(G)
Marcela García
(M)
María E Gervasoni
(ME)
Natalia Luconi
(N)
Mónica Matta Rufolo
(MM)
Víctor Skrie
(V)
Martín Bózzola
(M)
Norberto Procopio
(N)
Antonio Sánchez Segovia
(AS)
Irene Araoz
(I)
María C Cassaniti
(MC)
Elsa Mindel
(E)
Informations de copyright
Sociedad Argentina de Pediatría.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Cortada-Macías J, López-Serrano M, Blasco-Sarramián A, Mayorga C, et al. Introducción, conceptos generales, epidemiología. Fisiopatología: los fármacos como antígenos. In: Peláez-Hernández A, Dávila-González I.
Vervloet D, Durham S. Adverse reactions to drugs.
Gell P, Coombs R. Clinical aspects of immunology. Oxford: Blackwell Science; 1964.
Guvenir H, Dibek-Misirlioglu E, Vezir E, Toyran M, et al. Nonsteroidal anti-inflamatory drug hypersensitivity among children.
Cardona R, Ramírez R, Reina Z, Escobar M, et al. Alergia e intolerancia a antiinflamatorios no esteroides: desensibilización exitosa en tres casos y revisión de la literatura.
Caubet JC, Eigenmann P. Diagnostic issues in pediatric drug allergy.
Atanaskovic-Markovic M, Caubet J. Management of drug hypersensitivity in the pediatric population.
Kowalski M, Makowska J, Blanca M, Bavbek S, et al. Hypersensitivity to nonsteroidal anti-ininflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*.
Blanca-López N, Pérez-Alzate D, Andreu I, Doña I, et al. Immediate hypersensitivity reactions to ibuprofen and other arylpropionic acid derivates.
Atanaskovic-Markovic M, Gaeta F, Gavrovic-Jankulovic M, Cirkovic Velickovic T, et al. Diagnosing multiple drug hypersensitivity in children.
Toche Pinaud P. Alergia a antiinflamatorios no esteroidales.
Porto Arceo J. Particularidades de la intolerancia AINEs en niños.
Kowalski M, Asero R, Bavbek S, Blanca M, et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroideal antiinflammatory drugs.
Topal E, Celiksoy M, Catal F, Gamze Sayan Y, et al. The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children.
Blanca-López N, Cornejo-García J, Pérez-Alzate D, Pérez-Sánchez N, et-al. Hypersensitivity Reactions to Nonsteroidal Anti-inflammatory Drugs in Children and Adolescents: Selective Reactions.
Modena B, White A, Woessner K. Aspirin and nonsteroidal antiinflamatory drugs hypersensitivity and management.
White A, Stevenson D. Aspirin-exacerbated respiratory disease.
Cahill K, Boyce J. Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease.
Liu T, Kanaoka Y, Barret N, Feng C, et al. Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway.
Swierkosz T, Jordan L, McBride M, McGough K, et al. Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit.
Botting R. Mechanism of action of acetaminophen: is there a cyclooxygenase 3?
Sánchez-Borges M, Kidon M. Reactions to nonsteroidal anti-inflammatory drugs in children.
Kidon M, Blanca-López N, Gomes E, Terreehorst I, et al. EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal antiinflammatory drugs (NSAIDs) in children and adolescents.
García-Aviles M, Sanz-Larruga M, Lobera-Labairu T, Gracia-Bara M, et al. Diagnóstico de Alergia a Fármacos. In: Pelaez Hernandez A, Dávila González I.
Blanca-López N, Cornejo-García J, Plaza-Serón M, Dona I, et al. Hypersensitivity to Nonsteroidal Anti-inflammatory Drugs in Children and Adolescents: Cross-Intolerance Reactions.
Heelan K, Shear N. Cutaneous Drug Reactions in Children: an update.
Torres M, Barrionuevo E, Kowalski M, Blanca M. Hypersensitivity Reactions to Nonsteroidal AntiInflammatory Drugs.
Brockow K, Przybilla B, Aberer W, Bircher A, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM).
Echeverría Zudaire L, Del Olmo de la Lama M, Santana Rodríguez C. Anafilaxia en Pediatría.
De Schryver S, Halbrich M, Clarke A, La Vieille S, et al. Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors.
Gomes E, Brockow K, Kuyucu S, Saretta F, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group.
Alves C, Romeira A, Abreu C, Carreiro-Martins C, et al. Non-steroidal anti-inflammatory drug hypersensitivity in children.
Bousquet PJ, Gaeta F, Bousquet-Trouanet L, Lefrant JY, et al. Provocation Tests in Diagnosing Drug Hypersensitivity.
Ortega-Rodríguez N, Quiralte-Enriquez J, Frag-Lázaro J, Palacios-Colom L. Reacciones adversas a los AINE: alergia e intolerancia. In: Peláez Hernández A, Dávila González I.
Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity.
Blanca López N, Pérez Alzate D, Canto G, Blanca M. Practical approach to the treatment of NSAID hypersensitivity.
Kidon M, Liew W, Chiang W, Lim S, et al. Hypersensitivity to paracetamol in Asian children with early onset of nonsteroidal anti-inflammatory drug allergy.
Corzo J, Zambonino M, Muñoz C, Mayorga C, et al. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
Sánchez Borges M, Capriles-Hulett A, Caballero-Fonseca F, Pérez C. Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions.
Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
Loh W, Lim H, Rao R, Goh A, et al. Tolerance to etoricoxib in children with nonsteroidal anti-inflammatory drug hypersensitivity.
Levy D, Imundo L. Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data.
Murto K, Lamontagne C, McFaul C, MacCormick J, et al. Celecoxib pharmacogenetics and pediatric adenotonsillectomy: a double-blinded randomized controlled study.
Li X, Zhou M, Xia Q, Li J. Parecoxib sodium reduces the need for opioids after tonsillectomy in children: a doubleblind placebo-controlled randomized clinical trial.
Vázquez-Cortés S, Vázquez-Fuertes L, Rodríguez-Alvarez M, Reig Rincón de Arellano I, et al. Tolerancia a celecoxib y meloxicam en pacientes con intolerancia a analgésicos no esteroideos.
Scherer K, Brockow K, Aberer W, Gooi J, et al. Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group.
Cernadas JR, Brockow K, Romano AW, Aberer W, et al. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement.
Barbaud A. Place of excipients in Systemic drug allergy.
Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, et al. Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper.